Amador Bioscience Acquires Ann Arbor Pharmacometrics Group (A2PG)
December 24, 2021
Amador Bioscience has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a specialist pharmacometrics and clinical pharmacology consulting firm based in Ann Arbor, Michigan. The deal expands Amador’s translational sciences and clinical pharmacology capabilities, combining A2PG’s modeling and simulation expertise with Amador’s global CRO services.
- Buyers
- Amador Bioscience
- Targets
- Ann Arbor Pharmacometrics Group (A2PG)
- Industry
- Healthcare Services
- Location
- Michigan, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ATHAGORAS Group Acquires CSO Pharma Consulting GmbH
November 18, 2024
Healthcare Services
ATHAGORAS Group has acquired CSO Pharma Consulting GmbH to expand and internationalize its pharmacovigilance, medical affairs, quality management and GDP consulting capabilities across the pharma and healthcare sectors. The deal adds a specialized provider of PV and regulatory support to ATHAGORAS' life‑sciences services platform while CSO retains focus on organic growth and continuity for clients and employees.
-
athagoras Acquires DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH
October 16, 2025
Healthcare Services
athagoras has acquired DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH, a German consultancy specialising in Regulatory Affairs and Pharmacovigilance, to strengthen its RA/PV capabilities and expand local capacity in Germany. The deal adds DiaMed's experienced team to athagoras' European life‑sciences services platform and complements existing operations including CSO Pharma and S-cubed.
-
Pharmaron Acquires Absorption Systems
November 9, 2020
Healthcare Services
Pharmaron Beijing Co., Limited acquired 100% of Absorption Systems for up to US$137.5 million in cash. The purchase brings Absorption Systems’ non-clinical DMPK/ADME and bioanalysis capabilities and U.S. lab footprint (Philadelphia, San Diego and Boston) into Pharmaron’s integrated drug R&D services platform to expand capabilities and U.S. presence.
-
Bayer AG Acquires Asklepios BioPharmaceutical (AskBio)
October 26, 2020
Biotechnology
Bayer AG agreed to acquire U.S.-headquartered Asklepios BioPharmaceutical (AskBio), adding AskBio's AAV-based gene therapy platform, IP and CDMO manufacturing capabilities to Bayer’s emerging cell and gene therapy unit. Bayer will pay $2.0 billion upfront plus up to $2.0 billion in potential milestone payments; existing minority shareholders TPG Capital and Vida Ventures supported the transaction.
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
HGS BioScience Acquires Pharmgrade
January 13, 2026
Agriculture
Paine Schwartz Partners–backed HGS BioScience has acquired Pharmgrade, an Idaho-based developer of microbial consortium products, to strengthen its microbial capabilities and expand its integrated biologicals platform. The deal enhances HGS's R&D, formulation and manufacturing depth and helps scale Pharmgrade’s microbial technologies to retailers and growers across North America.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.